Santosh Kumar Guru

9PUBLICATIONS
33CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMolecular targetsBiologically active moleculesHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 19, 2026
Synthesis, Biological Evaluation, and In Silico Analysis of Benzothiazolyl-Furano Thiazolidinones as Tubulin Polymerization Inhibitors.

|May 09, 2026
Autophagy-lysosomal dependency defines a vulnerable physiological state in drug-tolerant persister cells of triple-negative breast cancer.

|Mar 26, 2026
Correction to "Design of Novel 3-Pyrimidinylazaindole CDK2/9 Inhibitors with Potent In Vitro and In Vivo Antitumor Efficacy in a Triple-Negative Breast Cancer Model".

Umed Singh, Gousia Chashoo, Sameer U Khan

|Jan 18, 2026
Scaffold-Hopping of Natural Alkaloid Rutaecarpine: Synthesis and Anticancer-Apoptosis and Autophagy Effects of Indole-Based Analogs.

Mukul Yadav, Santanu Basak, Vaibhav Gupta

|Jan 16, 2026
Human Serum Albumin-Lipid Nanocapsules of Duvelisib for Hematological Cancers: Characterization, In-Vitro Cell-Culture, Toxicity and Pharmacokinetic Studies.

Srushti Mahajan, Mayur Aalhate, Anamika Sharma

|Oct 06, 2025
Discovery of 2-(4-Ureido-piperidin-1-yl)-4-morpholinothieno [3,2-D] Pyrimidines as Orally Bioavailable Phosphoinositide-3-Kinase Inhibitors with In Vitro and In Vivo Antitumor Efficacy in Triple-Negative Breast Cancer.

Shabber Mohammed, Shabu Thakur, Diksha Manhas

Pageof 2

Frequent Collaborators

2 joint publications

Utpal Nandi

2 joint publications

Alakh N Sahu

2 joint publications

Singh Shreya

2 joint publications

Debadatta Mohapatra